Savient Pharmaceuticals has appointed a new finance chief.
A former Johnson & Johnson executive has been appointed to serve as interim CEO for Savient Pharmaceuticals.
Patients with gout taking a drug made by Savient Pharmaceuticals experienced "significant" improvements, according to results of two late-stage clinical trials published in the Journal of the American Medical Association.
Savient Pharmaceuticals announced changes to its management team as it gears up for the commercial launch of its chronic gout treatment.
Drug maker Savient Pharmaceuticals has begun shipping its new gout treatment to specialty distributors, the company said Tuesday.
Drug maker Savient Pharmaceuticals will begin shipping its treatment for chronic gout to specialty distributors...
The Food and Drug Administration has approved a new treatment for gout, a painful condition...